Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 6.89
-1.01 (-12.78%)
Sep 25, 2026, 12:11 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 60.31 million as of September 24, 2026. Its market cap has increased by 124.69% in one year.
Market Cap
60.31M
Enterprise Value
52.60M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.89
ChartMarket Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has increased from 53.75M to 60.31M, an increase of 12.21%. That is a compound annual growth rate of 2.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 60.31M | 116.26% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PureTech Health | 275.09M |
| Scancell Holdings | 117.59M |
| 4basebio | 87.40M |
| Bioventix | 80.99M |
| Faron Pharmaceuticals Oy | 72.29M |
| Ondine Biomedical | 55.85M |
| Sareum Holdings | 42.96M |
| Arecor Therapeutics | 33.04M |